HCA Healthcare, Inc. $HCA Stock Acquired by Miller Howard Investments Inc. NY

Miller Howard Investments Inc. NY boosted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 19.7% during the third quarter, Holdings Channel.com reports. The institutional investor owned 10,941 shares of the company’s stock after acquiring an additional 1,800 shares during the period. Miller Howard Investments Inc. NY’s holdings in HCA Healthcare were worth $4,669,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. MidFirst Bank purchased a new stake in HCA Healthcare during the 2nd quarter worth about $28,000. Clearstead Trust LLC purchased a new position in HCA Healthcare in the 2nd quarter valued at about $29,000. Cedar Mountain Advisors LLC acquired a new stake in shares of HCA Healthcare during the 1st quarter worth about $33,000. Delos Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare during the second quarter worth about $35,000. Finally, Indiana Trust & Investment Management Co purchased a new position in shares of HCA Healthcare during the third quarter valued at approximately $41,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have commented on HCA. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of HCA Healthcare in a research note on Friday, October 2nd. Deutsche Bank Aktiengesellschaft set a $476.00 price target on HCA Healthcare in a research note on Monday, July 27th. TD Cowen raised their price objective on HCA Healthcare from $431.00 to $460.00 and gave the stock a “buy” rating in a report on Monday, October 12th. Royal Bank Of Canada lifted their price objective on HCA Healthcare from $435.00 to $496.00 and gave the company an “outperform” rating in a research report on Wednesday, October 7th. Finally, Truist Financial reduced their target price on HCA Healthcare from $535.00 to $495.00 and set a “buy” rating on the stock in a research report on Monday, July 27th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $467.50.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $464.45 on Tuesday. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52. The firm has a 50 day moving average price of $431.57 and a 200 day moving average price of $445.15. The company has a market cap of $100.55 billion, a price-to-earnings ratio of 15.55, a PEG ratio of 1.58 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The company had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. HCA Healthcare’s revenue was up 8.7% on a year-over-year basis. During the same quarter last year, the firm posted $6.84 earnings per share. Sell-side analysts predict that HCA Healthcare, Inc. will post 29.51 EPS for the current year.

HCA Healthcare Company Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.